David A. Socks - Sep 21, 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director
Signature
/s/ Larry Miller, Attorney-in-Fact for David A. Socks
Stock symbol
PHAT
Transactions as of
Sep 21, 2021
Transactions value $
-$587,351
Form type
4
Date filed
9/23/2021, 08:37 PM
Previous filing
Aug 18, 2021
Next filing
Oct 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$445K -13.6K -1.09% $32.79 1.23M Sep 21, 2021 David A. Socks 2013 Revocable Trust F1, F2
transaction PHAT Common Stock Sale -$10.8K -324 -0.03% $33.31 1.23M Sep 21, 2021 David A. Socks 2013 Revocable Trust F3
transaction PHAT Common Stock Sale -$131K -4.1K -0.33% $32.06 1.23M Sep 22, 2021 David A. Socks 2013 Revocable Trust F4
holding PHAT Common Stock 410 Sep 21, 2021 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.1650. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.36. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.66 to $32.57. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.